Evidence map›Paper›PMID 9472039›Full record

ArticleThe Journal of cell biology1998

Smy1p, a kinesin-related protein that does not require microtubules.

S H Lillie, S S Brown

Abstract read
In one paragraph

Article in The Journal of cell biology, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Two kinesin-like proteins mediate actin-based chloroplast movement in Arabidopsis thaliana.Proceedings of the National Academy of Sciences of the United States of America · 2010
    Article
  11. Article
  12. Article
  13. Slip sliding away with myosin V.Proceedings of the National Academy of Sciences of the United States of America · 2007
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. dsu functions in a MYO5A-independent pathway to suppress the coat color of dilute mice.Proceedings of the National Academy of Sciences of the United States of America · 2004
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

S H LillieDepartment of Anatomy and Cell Biology, University of Michigan Medical School, Ann Arbor, Michigan 48109-0616, USA.
S S Brown

Funding

ZINC GLUCONATE GLYCINE LOZENGES &VITAMIN C EFFECTS ON COMMON COLDM01RR000042 · NCRR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RUBENFIRE, MELVYN · 1985 to 2007
$40.8M
MOTOR PROTEINS IN YEASTR01GM046745 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BROWN, SUSAN S. · 1992 to 1999
–
NCRR NIH HHS M01 RR000042NCRR NIH HHS M01RR00042NIGMS NIH HHS R01GM46745
6 · The paper itself

Abstract

We have previously reported that a defect in Myo2p, a myosin in budding yeast (Saccharomyces cerevisiae), can be partially corrected by overexpression of Smy1p, which is by sequence a kinesin-related protein (Lillie, S.H., and S.S. Brown. 1992. Nature. 356:358- 361). Such a functional link between putative actin- and microtubule-based motors is surprising, so here we have tested the prediction that Smy1p indeed acts as a microtubule-based motor. Unexpectedly, we found that abolition of microtubules by nocodazole does not interfere with the ability of Smy1p to correct the mutant Myo2p defect, nor does it interfere with the ability of Smy1p to localize properly. In addition, other perturbations of microtubules, such as treatment with benomyl or introduction of tubulin mutations, do not exacerbate the Myo2p defect. Furthermore, a mutation in SMY1 strongly predicted to destroy motor activity does not destroy Smy1p function. We have also observed a genetic interaction between SMY1 and two of the late SEC mutations, sec2 and sec4. This indicates that Smy1p can play a role even when Myo2p is wild type, and that Smy1p acts at a specific step of the late secretory pathway. We conclude that Smy1p does not act as a microtubule-based motor to localize properly or to compensate for defective Myo2p, but that it must instead act in some novel way.

Indexed as

Myosin Heavy ChainsMyosin Type IIMyosin Type VSaccharomyces cerevisiae ProteinsSchizosaccharomyces pombe ProteinsCarrier ProteinsFungal ProteinsGenes, LethalKinesinsMicrotubule-Associated ProteinsMicrotubulesMutationSaccharomyces cerevisiaeCarrier ProteinsFungal ProteinsKinesinsMicrotubule-Associated ProteinsMYO2 protein, S cerevisiaeMYO2 protein, S pombeMyosin Heavy ChainsMyosin Type IIMyosin Type VSaccharomyces cerevisiae ProteinsSchizosaccharomyces pombe Proteins

Identifiers

PMID9472039
PMCPMC2141741

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.